Related Experiment Videos
[Initial experiences with thrombolysis in Swiss hospitals. Synopsis of a round-table discussion]
H P Krayenbühl1, H Ziegler, T Moccetti
1Medizinische Poliklinik, Universitätsspital, Zürich.
Insights
Rapid thrombolytic therapy for acute myocardial infarction (AMI) significantly reduces mortality and preserves heart function. Prompt patient recognition of AMI symptoms and swift medical intervention are crucial for effective treatment.
Area of Science:
- Cardiology
- Emergency Medicine
- Pharmacology
Context:
- Acute myocardial infarction (AMI) treatment has evolved with thrombolytic therapy.
- Significant reductions in mortality and infarct size have been observed.
- Preservation of left ventricular function is a key outcome.
Purpose:
- To establish consensus on recommendations for efficient thrombolytic therapy in AMI.
- To outline optimal timing and adjunctive treatments for AMI.
- To define protocols for managing reperfusion and identifying recurrent ischemia.
Summary:
- Shorten the prehospital phase by increasing patient awareness of AMI symptoms and the need for immediate hospitalization.
- Administer intravenous thrombolysis within 3 hours of pain onset for all AMI cases, extending to 6 hours for large infarctions, after ruling out contraindications.
- Include heparinization and aspirin as accompanying medications. Monitor for recurrent ischemia, performing coronary arteriography for revascularization (PTCA or bypass surgery) if indicated. Conduct pre-discharge stress testing for asymptomatic patients.
Impact:
- Improved patient outcomes in acute myocardial infarction through timely and evidence-based thrombolytic interventions.
- Standardized treatment protocols for thrombolysis, heparinization, and aspirin administration.
- Enhanced diagnostic strategies for detecting recurrent ischemia, guiding further revascularization procedures.
Abstract:
Thrombolytic therapy of acute myocardial infarction (AMI) has resulted in significant reduction of mortality, limitation of infarct size and preservation of left ventricular function. Among the panelists there was consensus with respect to the following recommendations for efficient thrombolytic therapy of AMI: the prehospital phase should be considerably shortened, especially by reducing patient delay. This can be achieved by rendering patients aware of symptoms of AMI and the need for immediate hospitalization on their occurrence. After contraindications have been ruled out, intravenous thrombolysis should be started in every case where the time elapsed since the onset of pain is not greater than 3 hours. In patients with large infarctions intravenous thrombolysis is indicated up to 6 hours after onset of pain. Accompanying medication should include heparinization and administration of aspirin. When reperfusion is achieved the patient should be monitored for recurrence of ischemia. Regardless of symptoms recurrence of ischemia requires immediate coronary arteriography with a view to revascularization by PTCA or bypass surgery. Patients without recurrence of spontaneous ischemia should undergo ergometric stress testing before leaving the hospital. Exercise-induced angina or ST segment depression are strong indications for coronary arteriography.